Aptamer Gint4.T, targeting the human platelet-derived growth factor receptor PDGFRβ ectodomain overexpressed in GBM, inhibits in vitro GBM cell migration and proliferation and decreased in vivo tumor growth and differentiation [100]. Here, PDGFRB is linked to neoplasm.